NCT06040021

Brief Summary

The clinical and pathological features of early-onset colorectal cancer (EOCRC) differ from those of late-onset colorectal cancer (LOCRC). Our research aims to thoroughly elucidate the distinctions between them by analyzing clinical prognosis, metastatic patterns, gene expression, and genomic mutation profiles. Our deliberation will uncover latent strategies for personalized therapeutic of both EOCRC and LOCRC.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15,244

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2008

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
11 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
4.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 11, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 15, 2023

Completed
Last Updated

September 15, 2023

Status Verified

September 1, 2023

Enrollment Period

11 years

First QC Date

September 11, 2023

Last Update Submit

September 11, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • OS

    overall survival

    5 years after intervention

Study Arms (3)

EOCRC

Patients aged\<50 with colorectal cancer between 2008 and 2018 in Fudan university Shanghai cancer center.

Other: standardized treatment

IOCRC

Patients aged between 50 to 70 with colorectal cancer between 2008 and 2018 in Fudan university Shanghai cancer center.

Other: standardized treatment

LOCRC

Patients aged between≥70 with colorectal cancer between 2008 and 2018 in Fudan university Shanghai cancer center.

Other: standardized treatment

Interventions

Patients enrolled in these 2 cohorts all received standardized treatment of colorectal cancer.

EOCRCIOCRCLOCRC

Eligibility Criteria

Age16 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with colorectal cancer hospitalized in Fudan university Shanghai cancer center.

You may qualify if:

  • The initial diagnosis of colonoscopy and pathology belongs to colorectal cancer;
  • Patients should sign an informed consent form after fully understanding the purpose, procedures and potential risks of the study, indicating their voluntary participation in the research.

You may not qualify if:

  • Patients with obvious local or systemic severe infection;
  • Acute abdomen: intestinal obstruction, peritonitis, intestinal perforation;
  • Have a systemic underlying disease that has not been controlled, or is unstable;
  • Patients with poor physical fitness or serious other organic diseases who cannot tolerate anesthesia and surgery;
  • Women during pregnancy, perinatal and lactation;
  • Patients with severe mental disorders (such as schizophrenia, bipolar disorder, etc.) or patients who are mentally incapable or unable to understand the requirements for participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 11, 2023

First Posted

September 15, 2023

Study Start

January 1, 2008

Primary Completion

December 31, 2018

Study Completion

June 30, 2023

Last Updated

September 15, 2023

Record last verified: 2023-09